Clinical best practices in optimal monitoring, early diagnosis, and effective management of antibody-drug conjugate-induced interstitial lung disease or pneumonitis: a multidisciplinary team approach in Singapore.

导出 LinkOut

翻译打印收藏纠错

作者： Wei Peng,Yong ^[1] ; Felicia Sw,Teo ^[2] ; Lynette Ls,Teo ^[3] ; Matthew Ch,Ng ^[4] ; Tira J,Tan ^[5] ; Su Ying,Low ^[5] ; Karmen,Wong ^[6] ; Peter,Ang ^[7] ; Su Pin,Choo ^[8] ; Kim Hua,Lee ^[9] ; Soo Chin,Lee ^[10]

作者单位： National University Cancer Institute, Singapore, National University Health System, Singapore. ^[1] University Medicine Cluster, Division of Respiratory and Critical Care Medicine, National University Hospital, National University Health System, Singapore. ^[2] The Lung Clinic, Mount Elizabeth Medical Centre, Singapore. ^[3] Department of Diagnostic Imaging, National University Hospital, National University Health System, Singapore. ^[4] Division of Medical Oncology, National Cancer Centre Singapore, Singapore. ^[5] Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore. ^[6] Icon Cancer Centre, Mount Alvernia Hospital, Singapore. ^[7] Oncocare Cancer Centre, Mount Elizabeth Novena Medical Centre, Singapore. ^[8] Curie Oncology, Mount Elizabeth Hospital, Singapore. ^[9] Division of Oncology Nursing, National University Cancer Institute, Singapore, National University Health System, Singapore. ^[10]

关键词 Antibody–drug conjugate cancer treatment chemotherapy interstitial lung disease lung toxicity pneumonitis targeted therapy

主题词人类(Humans);新加坡(Singapore);肺疾病, 间质性(Lung Diseases, Interstitial);肺炎(Pneumonia);免疫轭合物(Immunoconjugates);早期诊断(Early Diagnosis);病人医疗小组(Patient Care Team)

DOI 10.1080/17425255.2022.2162383

PMID 36636012

发布时间 2023-02-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交